Pharmacyte Biotech Inc (OTCMKTS:PMCB) is about to start Phase 2b human clinical trial in pancreatic cancer in some time. Before the trial begins, the company…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) has decided to discuss some of its major milestones right before the phase 2b clinical trial in pancreatic cancer…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) may not be as large as many other biotech firms around the world, but the innovative technologies used by it are…
Leading biotech company Pharmacyte Biotech Inc (OTCMKTS:PMCB) is known for using high-end technologies to develop drugs for cancer and other diseases….
RADCOM Ltd. (NASDAQ:RDCM)’s 3Q performance results delivered stronger than expected EPS and revenue. The management signaled an upbeat tone at the release…
USANA Health Sciences, Inc. (NYSE:USNA) was one of the biggest gainers in trade Yesterday. The stock surged by close to 25 percent on the back of the company…
